When TNF-α was first discovered in 1975, it was regarded as an antitumor cytokine (Carswell et al. 1975) that was able to facilitate the vascular destruction of cancer cells and exert a synergistic effect with chemotherapy at cancer sites (Seynhaeve et al. 2007; Daniel and Wilson 2008). The gene discussed is TNF; the disease is cancer.